Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov;28(6):216-220.
doi: 10.1038/ijir.2016.31. Epub 2016 Aug 25.

Event-level Impact of Promescent on Quality of Sexual Experience in Men With Subjective Premature Ejaculation

Free PMC article

Event-level Impact of Promescent on Quality of Sexual Experience in Men With Subjective Premature Ejaculation

K P Mark et al. Int J Impot Res. .
Free PMC article


Promescent is a lidocaine-based ejaculation delaying spray that absorbs into the skin of the penis prior to sexual activity. This article aimed to evaluate the effect of Promescent on the experience of orgasm, ejaculatory latency time and quality of sexual experience (QSE). Additionally, we assessed ease of application of Promescent and the extent to which it enhanced or interrupted the sexual experience. The analytic sample consisted of 91 men with self-reported subjective premature ejaculation who were sent a sample of Promescent and completed a 14-day internet-based prospective daily electronic report. Average ejaculatory latency time was 11.16 min during product use events, compared with 6.81 min during product non-use events. Both members of the couple had an orgasm 65.6% of the time when they used the product, compared with 44.1% when they did not use the product. QSE was significantly improved on product use days (P<0.05). Quality also significantly improved each subsequent time the product was used (P<0.01). The product was reported as easy to use and did not interrupt the sexual experience. Findings suggest that the use of this topical spray significantly improves QSE and perception of partner experience, and that these improve with longer duration of use.

Conflict of interest statement

Dr Mark has consulted for Good in Bed, and has received compensation from Good in Bed. Dr Kerner is the Founder of Good in Bed, and has received funding from Absorption Pharmaceuticals, the makers of Promescent.


Figure 1
Figure 1
Orgasm experience with and without product use.

Similar articles

See all similar articles

Cited by 1 article


    1. McMahon CG, Althof SE, Waldinger MD, Porst H, Dean J, Sharlip ID et al. An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med 2008; 5: 1590–1606. - PubMed
    1. Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S, Alexander J. The premature ejaculation prevalence and attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol 2007; 51: 816–823. - PubMed
    1. Reading A, Wiest W. An analysis of self-reported sexual behavior in a sample of normal males. Arch Sex Behav 1984; 13: 69–83. - PubMed
    1. Spector IP, Carey M. Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav 1990; 19: 389. - PubMed
    1. Grenier G, Byers ES. The relationships among ejaculatory control, ejaculatory latency, and attempts to prolong heterosexual intercourse. Arch Sex Behav 1997; 26: 27–47. - PubMed